244 related articles for article (PubMed ID: 20712376)
61. Identification and characterization of a glycosaminoglycan recognition element of the C chemokine lymphotactin.
Peterson FC; Elgin ES; Nelson TJ; Zhang F; Hoeger TJ; Linhardt RJ; Volkman BF
J Biol Chem; 2004 Mar; 279(13):12598-604. PubMed ID: 14707146
[TBL] [Abstract][Full Text] [Related]
62. Chemokine-glycosaminoglycan binding: specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry.
Yu Y; Sweeney MD; Saad OM; Crown SE; Hsu AR; Handel TM; Leary JA
J Biol Chem; 2005 Sep; 280(37):32200-8. PubMed ID: 16033763
[TBL] [Abstract][Full Text] [Related]
63. Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation.
Crijns H; Vanheule V; Proost P
Front Immunol; 2020; 11():483. PubMed ID: 32296423
[TBL] [Abstract][Full Text] [Related]
64. Glycosaminoglycans mediate cell surface oligomerization of chemokines.
Hoogewerf AJ; Kuschert GS; Proudfoot AE; Borlat F; Clark-Lewis I; Power CA; Wells TN
Biochemistry; 1997 Nov; 36(44):13570-8. PubMed ID: 9354625
[TBL] [Abstract][Full Text] [Related]
65. Structural and functional basis of CXCL12 (stromal cell-derived factor-1 alpha) binding to heparin.
Murphy JW; Cho Y; Sachpatzidis A; Fan C; Hodsdon ME; Lolis E
J Biol Chem; 2007 Mar; 282(13):10018-10027. PubMed ID: 17264079
[TBL] [Abstract][Full Text] [Related]
66. Expression of the chemokine antagonist vMIP II using a non-viral vector can prolong corneal allograft survival.
Pillai RG; Beutelspacher SC; Larkin DF; George AJ
Transplantation; 2008 Jun; 85(11):1640-7. PubMed ID: 18551072
[TBL] [Abstract][Full Text] [Related]
67. Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo.
Lau EK; Paavola CD; Johnson Z; Gaudry JP; Geretti E; Borlat F; Kungl AJ; Proudfoot AE; Handel TM
J Biol Chem; 2004 May; 279(21):22294-305. PubMed ID: 15033992
[TBL] [Abstract][Full Text] [Related]
68. In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II.
Chen S; Bacon KB; Li L; Garcia GE; Xia Y; Lo D; Thompson DA; Siani MA; Yamamoto T; Harrison JK; Feng L
J Exp Med; 1998 Jul; 188(1):193-8. PubMed ID: 9653095
[TBL] [Abstract][Full Text] [Related]
69. Two glycosaminoglycan-binding domains of the mouse cytomegalovirus-encoded chemokine MCK-2 are critical for oligomerization of the full-length protein.
Pontejo SM; Murphy PM
J Biol Chem; 2017 Jun; 292(23):9613-9626. PubMed ID: 28432120
[TBL] [Abstract][Full Text] [Related]
70. Heterodimerization of CCR2 chemokines and regulation by glycosaminoglycan binding.
Crown SE; Yu Y; Sweeney MD; Leary JA; Handel TM
J Biol Chem; 2006 Sep; 281(35):25438-46. PubMed ID: 16803905
[TBL] [Abstract][Full Text] [Related]
71. Chemokine cooperativity is caused by competitive glycosaminoglycan binding.
Verkaar F; van Offenbeek J; van der Lee MMC; van Lith LHCJ; Watts AO; Rops ALWMM; Aguilar DC; Ziarek JJ; van der Vlag J; Handel TM; Volkman BF; Proudfoot AEI; Vischer HF; Zaman GJR; Smit MJ
J Immunol; 2014 Apr; 192(8):3908-3914. PubMed ID: 24639348
[TBL] [Abstract][Full Text] [Related]
72. Differential structural remodelling of heparan sulfate by chemokines: the role of chemokine oligomerization.
Dyer DP; Migliorini E; Salanga CL; Thakar D; Handel TM; Richter RP
Open Biol; 2017 Jan; 7(1):. PubMed ID: 28123055
[TBL] [Abstract][Full Text] [Related]
73. Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF-1alpha inhibit signaling by KSHV G protein-coupled receptor.
Geras-Raaka E; Varma A; Clark-Lewis I; Gershengorn MC
Biochem Biophys Res Commun; 1998 Dec; 253(3):725-7. PubMed ID: 9918794
[TBL] [Abstract][Full Text] [Related]
74. NMR Methods for Characterization of Glycosaminoglycan-Chemokine Interactions.
Pomin VH; Rajarathnam K
Methods Mol Biol; 2023; 2597():143-157. PubMed ID: 36374420
[TBL] [Abstract][Full Text] [Related]
75. Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites.
Goger B; Halden Y; Rek A; Mösl R; Pye D; Gallagher J; Kungl AJ
Biochemistry; 2002 Feb; 41(5):1640-6. PubMed ID: 11814358
[TBL] [Abstract][Full Text] [Related]
76. Differentiation of CC vs CXC chemokine dimers with GAG octasaccharide binding partners: an ion mobility mass spectrometry approach.
Seo Y; Andaya A; Bleiholder C; Leary JA
J Am Chem Soc; 2013 Mar; 135(11):4325-32. PubMed ID: 23418647
[TBL] [Abstract][Full Text] [Related]
77. Small molecule inhibitors of protein interaction with glycosaminoglycans (SMIGs), a novel class of bioactive agents with anti-inflammatory properties.
Harris N; Kogan FY; Il'kova G; Juhas S; Lahmy O; Gregor YI; Koppel J; Zhuk R; Gregor P
Biochim Biophys Acta; 2014 Jan; 1840(1):245-54. PubMed ID: 24060749
[TBL] [Abstract][Full Text] [Related]
78. The virus-encoded chemokine vMIP-II inhibits virus-induced Tc1-driven inflammation.
Lindow M; Nansen A; Bartholdy C; Stryhn A; Hansen NJ; Boesen TP; Wells TN; Schwartz TW; Thomsen AR
J Virol; 2003 Jul; 77(13):7393-400. PubMed ID: 12805438
[TBL] [Abstract][Full Text] [Related]
79. The human CC chemokine MIP-1beta dimer is not competent to bind to the CCR5 receptor.
Jin H; Shen X; Baggett BR; Kong X; LiWang PJ
J Biol Chem; 2007 Sep; 282(38):27976-83. PubMed ID: 17644519
[TBL] [Abstract][Full Text] [Related]
80. Structural basis of chemokine interactions with heparan sulfate, chondroitin sulfate, and dermatan sulfate.
Sepuru KM; Rajarathnam K
J Biol Chem; 2019 Oct; 294(43):15650-15661. PubMed ID: 31455633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
